Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CARDINAL HEALTH INC | Director | Common Shares | 52.7K | $5.65M | $107.08 | Nov 21, 2022 | Direct |
C4 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 32.5K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CCCC | C4 Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
CAH | CARDINAL HEALTH INC | Jun 30, 2023 | 1 | $0 | 5 | Aug 8, 2023 | Director |
CCCC | C4 Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
CAH | CARDINAL HEALTH INC | Nov 9, 2022 | 1 | $0 | 4 | Nov 10, 2022 | Director |
CCCC | C4 Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
CAH | CARDINAL HEALTH INC | Nov 11, 2021 | 1 | $0 | 4 | Nov 15, 2021 | Director |
CCCC | C4 Therapeutics, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |